Browsing by Author Novartis Pharmaceut

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Dec-2012Chronopharmacokinetics of Mycophenolic Acid and Its Glucuronide and Acyl Glucuronide Metabolites in Kidney Transplant Recipients Converted From Cyclosporine to EverolimusTedesco-Silva, Helio [UNIFESP]; Felipe, Claudia Rosso [UNIFESP]; Slade, Alan; Schmouder, Robert L.; Medina Pestana, Jose Osmar [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Novartis Inst Biomed Res; Novartis Pharmaceut
22-Apr-2010Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsHolman, Rury R.; Haffner, Steven M.; McMurray, John J.; Bethel, M. Angelyn; Holzhauer, Bjoern; Hua, Tsushung A.; Belenkov, Yuri; Boolell, Mitradev; Buse, John B.; Buckley, Brendan M.; Chacra, Antonio R. [UNIFESP]; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J.; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R.; Gaciong, Zbigniew; Gaztambide, Sonia; Giles, Thomas; Horton, Edward; Ilkova, Hasan; Jenssen, Trond; Kahn, Steven E.; Krum, Henry; Laakso, Markku; Leiter, Lawrence A.; Levitt, Naomi S.; Mareev, Viacheslav; Martinez, Felipe; Masson, Chantal; Mazzone, Theodore; Meaney, Eduardo; Nesto, Richard; Pan, Changyu; Prager, Rudolf; Raptis, Sotirios A.; Rutten, Guy E. H. M.; Sandstroem, Herbert; Schaper, Frank; Scheen, Andre; Schmitz, Ole; Sinay, Isaac; Soska, Vladimir; Stender, Steen; Tamas, Gyula; Tognoni, Gianni; Tuomilehto, Jaako; Villamil, Alberto S.; Vozar, Juraj; Califf, Robert M.; NAVIGATOR Study Grp; Univ Oxford; Univ Glasgow; Univ Leicester; Univ Texas Hlth Sci Ctr San Antonio; Duke Univ; Univ N Carolina; Novartis Pharmaceut; Univ Hosp Bern; Univ Bern; Moscow MV Lomonosov State Univ; Natl Univ Ireland Univ Coll Cork; Universidade Federal de São Paulo (UNIFESP); Natl Taiwan Univ Hosp; Univ Hosp; Chinese Univ Hong Kong; 301 Hosp; Calif State Univ Fresno; VA Cent Calif Hlth Care Syst; Univ Calif San Diego; Scripps Whittier Diabet Inst; Tulane Univ; Univ Sydney; Monash Univ; Warsaw Med Univ; Hosp Univ Cruces; Joslin Diabet Ctr; Istanbul Univ; Oslo Univ Hosp; Univ Tromso; VA Puget Sound Hlth Care Syst; Univ Washington; Univ Kuopio; Kuopio Univ Hosp; Univ Helsinki; S Ostrobothnia Cent Hosp; Univ Toronto; Univ Cape Town; Natl Univ Cordoba; Univ Buenos Aires; Univ Illinois; Hosp 10 Octubre; Lahey Clin Fdn; Krankenhaus Hietzing Neurolog; Attikon Univ Hosp; Univ Med Ctr; Umea Univ; Tech Univ Dresden; Univ Liege; Aarhus Univ; Univ Copenhagen; Fac Hosp St Anna; Semmelweis Univ; Ist Ric Farmacol Mario Negri; Diabetol Outpatient Clin
22-Apr-2010Effect of Valsartan on the Incidence of Diabetes and Cardiovascular EventsMcMurray, John J.; Holman, Rury R.; Haffner, Steven M.; Bethel, M. Angelyn; Holzhauer, Bjoern; Hua, Tsushung A.; Belenkov, Yuri; Boolell, Mitradev; Buse, John B.; Buckley, Brendan M.; Chacra, Antonio R. [UNIFESP]; Chiang, Fu-Tien; Charbonnel, Bernard; Chow, Chun-Chung; Davies, Melanie J.; Deedwania, Prakash; Diem, Peter; Einhorn, Daniel; Fonseca, Vivian; Fulcher, Gregory R.; Gaciong, Zbigniew; Gaztambide, Sonia; Giles, Thomas; Horton, Edward; Ilkova, Hasan; Jenssen, Trond; Kahn, Steven E.; Krum, Henry; Laakso, Markku; Leiter, Lawrence A.; Levitt, Naomi S.; Mareev, Viacheslav; Martinez, Felipe; Masson, Chantal; Mazzone, Theodore; Meaney, Eduardo; Nesto, Richard; Pan, Changyu; Prager, Rudolf; Raptis, Sotirios A.; Rutten, Guy E. H. M.; Sandstroem, Herbert; Schaper, Frank; Scheen, Andre; Schmitz, Ole; Sinay, Isaac; Soska, Vladimir; Stender, Steen; Tamas, Gyula; Tognoni, Gianni; Tuomilehto, Jaako; Villamil, Alberto S.; Vozar, Juraj; Califf, Robert M.; NAVIGATOR Study Grp; Univ Glasgow; Univ Oxford; Univ Texas Hlth Sci Ctr San Antonio; Duke Univ; Novartis Pharmaceut; Moscow MV Lomonosov State Univ; Univ N Carolina; Natl Univ Ireland Univ Coll Cork; Universidade Federal de São Paulo (UNIFESP); Natl Taiwan Univ Hosp; Univ Hosp; Chinese Univ Hong Kong; Univ Leicester; Calif State Univ Fresno; VA Cent Calif Hlth Care Syst; Univ Hosp Bern; Univ Bern; Univ Calif San Diego; Scripps Whittier Diabet Inst; Tulane Univ; Univ Sydney; Warsaw Med Univ; Hosp Univ Cruces; Joslin Diabet Ctr; Istanbul Univ; Oslo Univ Hosp; Univ Tromso; VA Puget Sound Hlth Care Syst; Univ Washington; Monash Univ; Univ Kuopio; Kuopio Univ Hosp; Univ Toronto; Univ Cape Town; Natl Univ Cordoba; Univ Illinois; Hosp Primero Octubre; Lahey Clin Fdn; 301 Hosp; Krankenhaus Hietzing Neurol; Attikon Univ Hosp; Univ Med Ctr; Umea Univ; Tech Univ Dresden; Univ Liege; Aarhus Univ; Inst Cardiovasc Buenos Aires; Fac Hosp St Anna; Univ Copenhagen; Semmelweis Univ; Ist Ric Farmacol Mario Negri; Univ Helsinki; S Ostrobothnia Cent Hosp; Univ Buenos Aires; Diabetol Outpatient Clin
1-Jul-2013Efficacy of Sotrastaurin Plus Tacrolimus After de Novo Kidney Transplantation: Randomized, Phase II Trial ResultsRuss, G. R.; Tedesco-Silva Junior, Hélio [UNIFESP]; Kuypers, D. R.; Cohney, S.; Langer, R. M.; Witzke, O.; Eris, J.; Sommerer, C.; von Zur-Muehlen, B.; Woodle, E. S.; Gill, J.; Ng, J.; Klupp, J.; Chodoff, L.; Budde, K.; Univ Adelaide; Universidade Federal de São Paulo (UNIFESP); Katholieke Univ Leuven Hosp; Royal Melbourne Hosp; Semmelweis Univ; Univ Duisburg Essen; Royal Prince Alfred Hosp; Univ Heidelberg Hosp; Uppsala Univ; Univ Cincinnati; St Pauls Hosp; Novartis Pharmaceut; Novartis Pharma AG; Charite
1-May-2012Everolimus Versus Sirolimus Maintenance Immunosuppression on Graft Survival Following Kidney Transplantation Using the UNOS/OPTN Database.Cibrik, Diane; Irish, W.; Kim, Y.; Geissler, F.; Tedesco-Silva, Helio [UNIFESP]; Univ Michigan; CTI Clin Trial & Consulting Serv; Novartis Pharmaceut; Universidade Federal de São Paulo (UNIFESP)
1-Sep-2009FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter studyTedesco-Silva, H. [UNIFESP]; Lorber, M. I.; Foster, C. E.; Sollinger, H. W.; Mendez, R.; Carvalho, D. B.; Shapiro, R.; Rajagopalan, P. R.; Mayer, H.; Slade, J.; Kahan, B. D.; FTY720A2202 Clinical Study Grp; Universidade Federal de São Paulo (UNIFESP); Yale Univ; UCI Med Ctr; Univ Wisconsin; Natl Inst Transplantat; Hosp Geral Bonsucesso; Univ Pittsburgh; Med Univ S Carolina; Novartis Pharma AG; Novartis Pharmaceut; Univ Texas Med Sch
1-May-2012Impact of Everolimus-Based Immunosuppression on Graft Survival Following Kidney Transplantation.Tedesco-Silva, Helio [UNIFESP]; Irish, W.; Kim, Y.; Geissler, F.; Cibrik, D.; Univ Michigan; Clin Trial & Consulting Serv; Novartis Pharmaceut; Universidade Federal de São Paulo (UNIFESP)
1-Jul-2010Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipientsTedesco-Silva, Helio [UNIFESP]; Felipe, Claudia R. [UNIFESP]; Park, Sung I. [UNIFESP]; Pinheiro-Machado, Paula G. [UNIFESP]; Garcia, Riberto [UNIFESP]; Slade, Alan; Schmouder, Robert; Medina-Pestana, Jose O. [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Novartis Pharmaceut
1-Apr-2014Randomized Phase III Trial Exploring the Use of LongActing Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: the LARCID TrialHoff, Paulo M.; Saragiotto, Daniel F.; Barrios, Carlos H.; del Giglio, Auro; Coutinho, Anelisa K.; Andrade, Aline C.; Dutra, Carolina; Forones, Nora M. [UNIFESP]; Correa, Mariangela; Portella, Maria do Socorro O.; Passos, Vanessa Q.; Chinen, Renata N.; van Eyll, Brigitte; Hosp Sirio Libanes; Fac Med ABC; Universidade Federal de São Paulo (UNIFESP); Hosp Alemao Oswaldo Cruz; Novartis Biociencias; Inst Canc Arnaldo Vieira de Carvalho; Hosp Sao Lucas; Clin Assistencia Multidisciplinar Oncol; Biocancer; Ctr Pesquisas Oncol; Novartis Pharmaceut
1-Nov-2013Search for New Endpoints for Clinical Trials of Immunosuppressive Drugs in Kidney TransplantationTedesco-Silva, Helio [UNIFESP]; Bernhardt, Peter; Dong, Gaohong; Escrig, Cesar; Universidade Federal de São Paulo (UNIFESP); Novartis Pharma AG; Novartis Pharmaceut